Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:TRIL
Delisted

Trillium Therapeutics Inc. Stock Price (Quote)

$18.44
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $18.44 $18.44 Friday, 27th May 2022 TRIL stock ended at $18.44. During the day the stock fluctuated 0% from a day low at $18.44 to a day high of $18.44.
90 days $18.44 $18.44
52 weeks $5.80 $18.49

Historical Trillium Therapeutics Inc. prices

Date Open High Low Close Volume
Jan 22, 2016 $8.36 $9.61 $8.13 $9.19 168 500
Jan 21, 2016 $8.31 $8.50 $8.00 $8.33 107 500
Jan 20, 2016 $7.52 $8.28 $7.16 $8.20 139 000
Jan 19, 2016 $8.66 $8.66 $7.85 $7.90 62 900
Jan 15, 2016 $7.92 $8.40 $7.59 $8.34 127 700
Jan 14, 2016 $8.58 $8.88 $7.98 $8.19 456 700
Jan 13, 2016 $9.50 $9.87 $8.40 $8.55 62 200
Jan 12, 2016 $9.98 $10.29 $9.10 $9.38 76 700
Jan 11, 2016 $11.33 $11.33 $9.32 $9.95 116 900
Jan 08, 2016 $11.19 $11.25 $10.79 $11.16 98 600
Jan 07, 2016 $11.45 $11.45 $9.94 $11.18 136 500
Jan 06, 2016 $12.22 $12.33 $11.12 $11.49 74 000
Jan 05, 2016 $12.68 $13.24 $12.27 $12.44 70 900
Click to get the best stock tips daily for free!

About Trillium Therapeutics Inc.

Trillium Therapeutics. Trillium Therapeutics Inc., an immuno-oncology company, develops therapies for the treatment of cancer. The company’s lead program is SIRPaFc, an antibody-like fusion protein, which is in Phase I clinical trial that blocks the activity of CD47 to promote the macrophage-mediated killing of tumor cells in a range of cancers. It also develops CD200 monoclonal antibody that blocks the activity of CD200 to evade attack from the immune system. The com... TRIL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT